Elysium Therapeutics announced it raised $2.23 Million in an amended filing from an offering of $9.13 Million
Elysium Therapeutics announced it raised $2.23 Million in an amended filing from an offering of $9.13 Million
10/11/22, 4:50 PM
Location
akronMoney raised
$2.23 million
Industry
biotechnology
Round Type
seed
Company Info
Location
1201 east market st., suite 604
akron, ohio, united states
Additional Info
Elysium’s mission is to reduce suffering from severe acute pain, opioid-use disorder (OUD), and fatal opioid overdose by developing first- or best-in-class products with profiles that address the key limitations and dangers associated with opioids used today. Our pipeline consists of 3 diverse platforms with broad applicability across several areas of significant unmet need: